Brief: Neuland Labs Says No Form 483 Issued After Inspection Of Facility At Pashmylaram
29/11/2018 09:04
Nov 29 (Reuters) - Neuland Laboratories Ltd NEUL.NS :
* US FDA INSPECTED ONE OF MANUFACTURING FACILITIES LOCATED
AT
PASHMYLARAM, PATANCHERU MANDAL, SANGAREDDY DISTRICT
* SAYS INSPECTION AT UNIT 2 BY U.S, FDA SUCCESSFULLY
COMPLETED
WITH NO OBSERVATIONS UNDER FORM 483
Source text - http://bit.ly/2Q3qy6k
Further company coverage: NEUL.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Neuland Laboratories
See all newsIndia's Neuland Laboratories jumps after approving $13.3 mln land purchase for expansion
Brief: Neuland Laboratories Approves Capital Expenditure Of 1.26 Billion Rupees For Land Purchase In Kakinada
Brief: Neuland Laboratories Says US FDA Inspects Neuland Laboratories Unit 3 From August 10 To 14, 2026
Brief: Neuland Laboratories June-Quarter Consol Profit 1.48 Billion Rupees
Brief: Neuland Laboratories March-Quarter Consol Profit 2.13 Bln Rupees